After an era of biology-oriented spending—largely driven by Big Pharma and government concerns about bioterrorism—climate change is reshaping priorities in science and technology construction. “Engineering and chemistry funding are going up now, as is energy research, which seems to continue to get federal funding,” says Andy Vazzano, FAIA, LEED AP, Science and Technology Practice Leader at SmithGroupJJR. “Meanwhile, the sequester and budget cuts are having a negative impact on NIH funding for biomedical research.”
The focus on human health hasn’t totally faded, with many research universities still building new labs—especially those that tie research to clinical practice. “Anything that begins with ‘trans’ or ‘inter’ is still a major trend,” says Ryan Abbott, Science and Technology Project Director at Sundt Construction and a BD+C “40 Under 40” honoree (Class of 2012). “Translational, interdisciplinary. Modern science is a team sport.”
TOP S&T SECTOR ARCHITECTURE FIRMS
2012 S+T Revenue ($)1 HDR Architecture $91,252,0002 Perkins+Will $48,373,5683 HOK $38,347,0004 Stantec $33,111,4695 SmithGroupJJR $26,400,0006 Flad Architects $21,480,0007 Payette $18,434,0298 ZGF Architects $16,214,2679 EwingCole $11,000,00010 FKP Architects $10,250,000
TOP S&T SECTOR ENGINEERING FIRMS
2012 S+T Revenue ($)1 Affiliated Engineers $19,824,0002 Middough $13,900,0003 URS Corp. $11,772,1244 Bard, Rao + Athanas Consulting Engineers $10,500,0005 RMF Engineering Design $9,200,0006 Vanderweil Engineers $7,851,9007 Paulus, Sokolowski and Sartor $7,500,0008 WSP USA $5,772,0959 Science Applications International Corp. $3,103,15210 STV $2,937,000
TOP S&T SECTOR CONSTRUCTION FIRMS
2012 S+T Revenue ($)1 Skanska USA $376,717,4742 DPR Construction $298,563,6423 Suffolk Construction $290,560,3074 Manhattan Construction $199,444,0005 Whiting-Turner Contracting Co., The $193,160,4256 JE Dunn Construction $184,799,0517 Clark Group $174,348,8048 Turner Corporation, The $157,490,0009 Structure Tone $143,798,00010 Consigli Construction $74,568,263
Though the purpose-built med school building is the iconic face of S+T, adaptive reuse is getting a second look for advantages in cost and speed. Many clients are also seeking higher levels of green; LEED Platinum, once thought impossible for labs, is no longer unique, and clients are increasingly eyeing net-zero.
In addition, look for public/private partnerships to assume a greater role, even in the rarefied atmosphere of the Ivy League. Harvard, for instance, has rethought its Allston science campus during a recession hiatus. When the site cranks up again next year, the program will include a 36-acre, privately developed “enterprise research campus” for related companies in pharma, biotech, and venture capital.
Read BD+C's full Giants 300 Report
Related Stories
| Oct 4, 2013
Sydney to get world's tallest 'living' façade
The One Central Park Tower development consists of two, 380-foot-tall towers covered in a series of living walls and vertical gardens that will extend the full height of the buildings.
| Oct 4, 2013
Nifty video shows planned development of La Sagrada Familia basilica
After 144 years, construction on Gaudi's iconic Barcelona edifice is picking up speed, with a projected end date of 2026.
| Oct 4, 2013
Mack Urban, AECOM acquire six acres for development in LA's South Park district
Mack Urban and AECOM Capital, the investment fund of AECOM Technology Corporation (NYSE: ACM), have acquired six acres of land in downtown Los Angeles’ South Park district located in the central business district (CBD).
| Oct 4, 2013
CRB opens Atlanta office
Georgia’s status as a burgeoning hub for the life sciences industry has fueled CRB’s decision to open an office in Atlanta to better serve its clients in the market. CRB is a leading provider of engineering, design and construction services for customers in the biotech, pharmaceutical and life sciences industries.
| Sep 27, 2013
NYC releases first year-to-year energy performance data on commercial properties
A new report provides information on energy performance of New York City's largest buildings (mostly commercial, multi-family residential). It provides an analysis of 2011 data from city-required energy “benchmarking”—or the tracking and comparison of energy performance—in more than 24,000 buildings that are over 50,000 square feet.
| Sep 27, 2013
ASHRAE/IES publish first standard focused on commissioning process
ANSI/ASHRAE/IES Standard 202, Commissioning Process for Buildings and Systems, identifies the minimum acceptable commissioning process for buildings and systems as described in ASHRAE’s Guideline 0-2005, The Commissioning Process. Standard 202 is ASHRAE’s first standard focused on the commissioning process.
| Sep 26, 2013
6 ways to maximize home-field advantage in sports venue design
Home-field advantage can play a significant role in game outcomes. Here are ways AEC firms can help create the conditions that draw big crowds, energize the home team to perform better, and disrupt visiting players.
| Sep 26, 2013
Literature review affirms benefits of daylighting, architectural glazing
The use of glass as a building material positively impacts learning, healing, productivity and well-being, according to a white paper published by Guardian Industries and the University of Michigan Taubman College of Architecture and Urban Planning. The findings highlight the significant influence daylighting and outside views have on employees, workers, students, consumers and patients.
| Sep 26, 2013
Mobilizing your job site to achieve a paperless project: fact or fiction?
True mobility in the field has rapidly evolved from lock-box kiosks on each floor to laptops on rolling carts to tablets and iPads loaded with drawings sets stored in the cloud. And WiFi-ready job sites have gone from “nice to have” to “must have” status in just a little over a year.
| Sep 26, 2013
Leading in the face of change
As AEC firms navigate toward an uncertain future, the most effective leaders are those who eagerly adapt to change. Here are three attitudes that drive leaders who are of most value to their firms.